PRESS RELEASE published on 11/28/2025 at 13:10, 4 months 8 days ago Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown Xlife Sciences AG updates on VERAXA Biotech AG's NASDAQ listing process post U.S. Government Shutdown, SEC responds to Form F-4 filing, progress towards business combination with Voyager Acquisition Corp Nasdaq SEC Xlife Sciences AG VERAXA Biotech AG Voyager Acquisition Corp.
BRIEF published on 10/16/2025 at 07:05, 5 months 21 days ago Xlife Sciences AG publie son rapport ESG 2024 mettant en avant la croissance durable Croissance Durable Responsabilité Sociale Impact Environnemental Xlife Sciences Rapport ESG 2024
BRIEF published on 10/16/2025 at 07:05, 5 months 21 days ago Xlife Sciences AG Releases 2024 ESG Report Highlighting Sustainable Growth Environmental Impact Social Responsibility Sustainable Growth Xlife Sciences ESG Report 2024
PRESS RELEASE published on 10/16/2025 at 07:00, 5 months 21 days ago Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a Strategic Core Xlife Sciences AG publishes 2024 ESG Report showcasing sustainable value creation through integrating ESG principles into corporate strategy and portfolio management in life sciences sector Life Sciences Xlife Sciences AG ESG Principles Sustainable Value Creation 2024 ESG Report
BRIEF published on 09/23/2025 at 07:05, 6 months 13 days ago Xlife Sciences AG Focuses on VERAXA's NASDAQ Listing in H1 2025 Financial Performance Nasdaq Listing Global Partnerships Xlife Sciences Biotech Expansion
BRIEF published on 09/23/2025 at 07:05, 6 months 13 days ago Xlife Sciences AG se concentre sur l'introduction de VERAXA au NASDAQ au premier semestre 2025 Performance Financière Partenariats Mondiaux Xlife Sciences Cotation Au Nasdaq Expansion Biotechnologique
PRESS RELEASE published on 09/23/2025 at 07:00, 6 months 13 days ago Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Listing and Internationalization Xlife Sciences AG released its Half-Year Report 2025 with focus on VERAXA Biotech AG's NASDAQ listing and internationalization. Operational and financial highlights were shared along with clear priorities for H2 2025 Nasdaq Listing Xlife Sciences AG Internationalization VERAXA Biotech AG Half-Year Report 2025
BRIEF published on 07/17/2025 at 07:05, 8 months 20 days ago VERAXA Biotech AG progresse vers la cotation au NASDAQ grâce au dépôt du formulaire F-4 Cotation Au Nasdaq VERAXA Biotech Regroupement D'entreprises Dépôt Du Formulaire F-4 Thérapeutiques Oncologiques
BRIEF published on 07/17/2025 at 07:05, 8 months 20 days ago VERAXA Biotech AG Advances Toward NASDAQ Listing with Form F-4 Filing Nasdaq Listing Business Combination Oncology Therapeutics VERAXA Biotech Form F-4 Filing
PRESS RELEASE published on 07/17/2025 at 07:00, 8 months 20 days ago Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4 Xlife Sciences AG's portfolio company VERAXA Biotech AG takes a key step towards NASDAQ listing with the filing of Form F-4, signaling continued momentum and billion-dollar valuation in the public market journey Nasdaq Listing Business Combination Xlife Sciences AG VERAXA Biotech AG Form F-4
Published on 04/06/2026 at 15:15, 1 hour 30 minutes ago Datavault AI CEO Nathaniel T. Bradley to Deliver Flagship Keynotes on Breakthrough RWA Tokenization at CONV3RGENCE London and AssetRush × Zurich 2026
Published on 04/06/2026 at 14:02, 2 hours 43 minutes ago Black Iron annonce un placement privé d’unités pour un produit brut pouvant atteindre 1,7 million de dollars américains
Published on 04/06/2026 at 13:15, 3 hours 30 minutes ago Avino Announces Normal Course Issuer Bid for Common Shares
Published on 04/06/2026 at 13:00, 3 hours 45 minutes ago Revolve Signs Interconnection Agreement for 130 MW EL 24 Wind Project in Mexico
Published on 04/06/2026 at 15:50, 54 minutes ago Mesabi Metallics Secures $150 Million from Macquarie Group
Published on 04/06/2026 at 15:24, 1 hour 20 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/06/2026 at 15:23, 1 hour 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 04/06/2026 at 15:21, 1 hour 23 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 04/06/2026 at 15:00, 1 hour 45 minutes ago FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality
Published on 04/06/2026 at 15:00, 1 hour 45 minutes ago FinanceWire intègre Certidox pour permettre la vérification des communiqués de presse, alors que les contenus falsifiés deviennent impossibles à distinguer de la réalité
Published on 04/03/2026 at 18:46, 2 days 21 hours ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 2 days 21 hours ago Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 2 days 22 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL